Switzerland
As COO at MediCrops, I’m rethinking what a pharmaceutical company can be in the age of AI. We’re not layering AI onto legacy systems. We’re building from the ground up: lean, fast, and radically patient-centric. I lead operations across strategy, compliance, and technology to create a next-generation pharma model that’s agile, data-driven, and built for speed. Our focus is on enabling better access to care while staying deeply compliant with Swiss and European regulations. With a background in global go-to-market execution, real-world data, and digital health, I bring a pragmatic, execution-focused mindset to transforming healthcare. I operate at the intersection of clinical practice, AI enablement, and regulatory infrastructure—driving innovation that actually delivers for patients.
Leading and Executing the European launch and commercialization of Amgevita and other inflammation assets.
Globally responsible for all commercial strategy during development and launch phase, pre-launch preparation and delivery of tools to drive in-market success and maximize brand value across all customer groups.